Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

6.3%

1 terminated/withdrawn out of 16 trials

Success Rate

93.8%

+7.2% vs industry average

Late-Stage Pipeline

44%

7 trials in Phase 3/4

Results Transparency

27%

4 of 15 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

Phase 3

6(40.0%)

Phase 2

4(26.7%)

Phase 1

3(20.0%)

N/A

1(6.7%)

Phase 4

1(6.7%)

15Total

Phase 3(6)

Phase 2(4)

Phase 1(3)

N/A(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (16)

Showing 16 of 16 trials

NCT05227677Not ApplicableCompleted

Value of Glycated Albumin in Intervention of Glycemic Control in Chinese Patients With Type 2 Diabetes

Role: lead

NCT02792842Phase 2Completed

Exploratory Study of ART-123 for the Prevention of Cancer Treatment Related Symptoms in Patients With Postoperative Stage II / III Colon Cancer

Role: lead

NCT04483297Phase 1Terminated

First-In-Human Study of AK1320 Encapsulated Microspheres (AK1320 MS)

Role: lead

NCT03471988Phase 3Completed

Clinical Study of AK1820 (Isavuconazonium Sulfate) for the Treatment of Deep Mycosis

Role: lead

NCT02489773Completed

Lucica ® Glycated Albumin-L Clinical Program - Pivotal Study

Role: lead

NCT02256150Phase 3Completed

A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Lupus Nephritis

Role: lead

NCT02739165Phase 3Completed

Clinical Study of ART-123 for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Role: lead

NCT02257697Phase 3Completed

A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Refractory Nephrotic Syndrome

Role: lead

NCT01588353Phase 3Completed

Collagenase Option for Reduction of Dupuytren's Contracture in Japan

Role: lead

NCT01935479Phase 1Completed

A Phase I Study of AK159 in Healthy Postmenopausal Women

Role: lead

NCT01704001Phase 4Completed

Clinical Pharmacokinetics Study of ART-123 in Disseminated Intravascular Coagulation (DIC) Subjects With Renal Impairment

Role: lead

NCT01623622Phase 2Completed

Study of HC-58 in Upper Limb Hemiplegic Patients After Stroke

Role: lead

NCT01285752Phase 2Completed

A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA)

Role: lead

NCT01551602Phase 1Completed

Clinical Study of AK159 in Healthy Postmenopausal Women

Role: lead

NCT00902369Phase 2Completed

A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA)

Role: lead

NCT01522521Phase 3Completed

Study of AK156 in Primary Osteoporosis Patients

Role: lead

All 16 trials loaded